{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Familial tumour syndromes of the central and peripheral nervous system",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_doxorubicin",
          "name": "Doxorubicin"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_temozolomide",
          "name": "Temozolomide"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_vincristine",
          "name": "Vincristine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_etoposide",
          "name": "Etoposide"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_bleomycin",
          "name": "Bleomycin"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_ifosfamide",
          "name": "Ifosfamide"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_nitrosoureas",
          "name": "Nitrosoureas"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_procarbazine",
          "name": "Procarbazine"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_bortezomib",
          "name": "Bortezomib"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_thalidomide",
          "name": "Thalidomide"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_target1",
          "type": "Target",
          "label": "DNA",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target2",
          "type": "Target",
          "label": "Topoisomerase II",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway1",
          "type": "Pathway",
          "label": "Apoptosis Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway2",
          "type": "Pathway",
          "label": "Cell Cycle Arrest Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_disease",
          "type": "Disease",
          "label": "Familial Tumour Syndromes",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph1",
          "type": "Phenotype",
          "label": "Tumor Growth",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph2",
          "type": "Phenotype",
          "label": "Neurotoxicity",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_cyclophosphamide",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知氮芥类药物作用于DNA"
        },
        {
          "source": "drug_doxorubicin",
          "target": "n_target2",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "已有实验证据支持其与拓扑异构酶 II 结合"
        },
        {
          "source": "n_target1",
          "target": "n_pathway1",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "DNA损伤通路与细胞凋亡密切相关"
        },
        {
          "source": "n_target2",
          "target": "n_pathway2",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "拓扑异构酶 II 在细胞周期调控中起重要作用"
        },
        {
          "source": "n_pathway1",
          "target": "n_ph1",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "细胞凋亡直接导致肿瘤生长抑制"
        },
        {
          "source": "n_pathway2",
          "target": "n_ph2",
          "relation": "causes",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "细胞周期停滞可引发神经毒性"
        },
        {
          "source": "drug_temozolomide",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "常用于胶质瘤的DNA烷化剂"
        },
        {
          "source": "drug_vincristine",
          "target": "n_pathway2",
          "relation": "modulates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知抑制微管聚合引起细胞周期停滞"
        },
        {
          "source": "drug_etoposide",
          "target": "n_target2",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "靶向拓扑异构酶 II 的经典药物"
        },
        {
          "source": "drug_bleomycin",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "已知导致DNA单链断裂"
        },
        {
          "source": "drug_ifosfamide",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "类似于环磷酰胺，影响DNA"
        },
        {
          "source": "drug_nitrosoureas",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "常用于脑肿瘤治疗的药物"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_ph2",
          "relation": "modulates",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "已知与神经系统相关的副作用"
        },
        {
          "source": "drug_procarbazine",
          "target": "n_ph1",
          "relation": "causes",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "与肿瘤生长相关临床发现"
        },
        {
          "source": "drug_bortezomib",
          "target": "n_pathway1",
          "relation": "modulates",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "已知影响凋亡通路"
        },
        {
          "source": "drug_thalidomide",
          "target": "n_ph2",
          "relation": "causes",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "可能导致神经毒性"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "H1",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "机制支持对肿瘤的影响"
        },
        {
          "source": "drug_doxorubicin",
          "target": "H2",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "对特定肿瘤类型有效的已知反应"
        },
        {
          "source": "drug_temozolomide",
          "target": "H3",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "对胶质瘤的有效性已知"
        },
        {
          "source": "drug_vincristine",
          "target": "H4",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "与细胞周期影响相关已知"
        },
        {
          "source": "drug_etoposide",
          "target": "H5",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "与细胞周期及肿瘤抑制作用相关"
        },
        {
          "source": "drug_bleomycin",
          "target": "H6",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "与重要的DNA损伤机制相关"
        },
        {
          "source": "drug_ifosfamide",
          "target": "H7",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "剽窃与环磷酰胺的药理关联"
        },
        {
          "source": "drug_nitrosoureas",
          "target": "H8",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "与类似肿瘤治疗药物响应一致"
        },
        {
          "source": "drug_methotrexate",
          "target": "H9",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "与潜在的神经影响有关"
        },
        {
          "source": "drug_procarbazine",
          "target": "H10",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "与预期肿瘤干预相关"
        },
        {
          "source": "drug_bortezomib",
          "target": "H11",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "可能涉及不同的机制"
        },
        {
          "source": "drug_thalidomide",
          "target": "H12",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "相关的潜在风险与神经影响"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "通过影响 DNA 和细胞周期，药物可能对家族性肿瘤综合症有贡献",
        "confidence": "medium"
      },
      {
        "id": "C2",
        "text": "多种药物的作用机制通路支持干预这一病症",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "药物具备到达相关生物靶标和效果的常识判断"
    ],
    "uncertainties": [
      "不同药物与神经系统的药理效应需要进一步确认"
    ],
    "next_focus_for_pi": [
      "是否需要进一步探索其他药物的机制在此病症中的作用"
    ]
  }
}